Astrazeneca plc

NASDAQ: AZN
$77.99
-$0.19 (-0.2%)
Closing Price on June 28, 2024

AZN Articles

Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward.
The top analyst upgrades, downgrades and initiations seen on Monday morning include Colgate-Palmolive, Gilead Sciences, Navistar, Occidental Petroleum, Pandora Media and Wal-Mart.
Major pharmaceuticals have been under fire in light of the recent Mylan EpiPen pricing fiasco, but now a key research firm is seeing one of these companies in a positive light.
The top analyst upgrades, downgrades and initiations seen on Monday morning include Harley-Davidson, HP, KeyCorp, KLA-Tencor, Netflix, Square and T-Mobile.
The broad markets are continuing to hit all-time highs as the market is shifting gears out of the earnings season. Despite all the positive sentiment in the market, quite a few companies still...
Credit Suisse sees the Bristol-Myers Squibb gap with Merck getting even worse, even though it still has robust I-O franchise estimates for Bristol-Myers.
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Accenture, Cognizant Technology Solutions, Fitbit, Oracle, Seagate Technology and Vodafone.
Perhaps the move for a rapid exit by Britain from the European Union (or Brexit) may have been interrupted due to a political murder of M.P. Jo Cox on Thursday. As this was a member of parliament,...
ASCO has just released the abstracts for its exhibitors ahead of the conference. For investors and analysts, sometimes winners or losers from the meeting can be divined ahead of time by these...
Several big FDA decisions should be coming up in the June quarter for the likes of AstraZeneca and Sarepta Therapeutics.
A pharmaceutical company could face a threat to one of its products for a number of reasons, ranging from an improved formulation to a patent expiry and the opening of the floodgates for generic...
Attaining a certain drug can mean the difference between life and death for millions of Americans. These essential products also help generate billions for drug manufacturers. Pharmaceutical...
Inovio Pharmaceuticals made waves early on Tuesday morning following an update for its human papillomavirus (HPV) treatment.
March 22, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in Tuesday’s session. AstraZeneca PLC (NYSE: AZN) dropped about 2.5% on...
Tuesday's top analyst initiations, upgrades and downgrades include AstraZeneca, 3D Systems, Barrick Gold, Home Depot, Oasis Petroleum and Whiting Petroleum.